Molds - Mold Mix 4

NDC 65044-5000 · Jubilant HollisterStier LLC

Generic nameMolds - Mold Mix 4

Dosage formINJECTION, SOLUTION

RoutePERCUTANEOUS, SUBCUTANEOUS

Active ingredient(s)ALTERNARIA ALTERNATA, ASPERGILLUS FUMIGATUS, ASPERGILLUS NIDULANS, ASPERGILLUS NIGER VAR. NIGER, ASPERGILLUS TERREUS, CLADOSPORIUM CLADOSPORIOIDES, PENICILLIUM DIGITATUM, PENICILLIUM EXPANSUM, PENICILLIUM CHRYSOGENUM VAR. CHRYSOGENUM, CLONOSTACHYS ROSEA F. ROSEA

Strength.1; .025; .025; .025; .025; .1; .025; .025; .025; .025 g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL

Pharmacologic classAllergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]

Marketing categoryBLA

Packages

65044-5000-2 — 10 mL in 1 VIAL (65044-5000-2)

65044-5000-3 — 30 mL in 1 VIAL (65044-5000-3)

65044-5000-4 — 50 mL in 1 VIAL (65044-5000-4)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

58264-0314 — ASPERGILLUS FLAVUS, ASPERGILLUS FUMIGATUS, EUROTIUM HERBARIORUM, ASPERGILLUS NIDULANS, ASPERGILLUS NIGER VAR. NIGER, PENICILLIUM…, 59623-013 — Kali Muriaticum, Gelsemium, Kali Bichromicum, Sabadilla, Histaminum, Mold Mix., 62713-974 — Alternaria Tenuis, Aspergillus Mixture, Botrytis Cinerea, Chaetomium Globosum, Cladosporium Cladosporioides, Curvularia, Epicoccum Nigrum,…, 63083-4001 — Mycosis Nosode, 63083-4021 — Low Mycosis Nosode, 63083-4029 — Nail Fungus Nosode, 63083-6010 — Mycological Immune Stimulator, 63083-6020 — Mycotoxin Inhibitor, 63083-9401 — Fungus Nosode Combination, 63479-0111 — ALLIUM SATIVUM, ALTERNARIA ALTERNATA, ASCORBICUM ACIDUM, ASPERGILLUS NIGER, AUREOBASIDIUM PULLULANS, BERBERIS VULGARIS, CADMIUM METALLICUM,…, 65044-5002 — Molds - Mold Mix 4, 65044-5003 — Molds - Alternaria/Hormodendrum Mix, 65044-5004 — Molds - Alternaria/Hormodendrum Mix, 65044-5008 — Alternaria tenuis, 65044-5009 — Alternaria tenuis, 65044-5020 — Aspergillus fumigatus, 65044-5021 — Aspergillus fumigatus, 65044-5032 — Aspergillus niger, 65044-5033 — Aspergillus niger, 65044-5128 — Hormodendrum cladosporioides, +132 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels